Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kodiak Sciences Inc.KOD · Entity 4388 | See Remarks | June 24, 2023 | June 27, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kodiak Sciences Inc.
Report date June 24, 2023 · Filed June 27, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.24 · Expires 2033-06-23 | Direct | 207,500 |
Reported balance
After 2023-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-24 · Grant · Acquired 207,500 · Balance 207,500 F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: One-forty-eighth (1/48th) of the shares vest one month after July 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of forty-seven (47) successive equal monthly installments measured from the first month anniversary of the Vesting Commencement Date, subject to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 751 | $71.27 | $53,523.62 |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,739 F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $70.88 to $71.705, inclusive. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 553 | $69.91 | $38,662.11 |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,490 F3 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $69.65 to $70.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Tax withholdingCommon Stock | 3,941 | $71.25 | $280,796.25 |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,043 F2 · kind: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of 25% of the Reporting Person's restricted stock units granted on October 9, 2018. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 23:04 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-054733 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · derivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,575 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 19 | $56.75 | $1,078.25 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,984 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 545 | $54.23 | $29,556.71 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,003 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $54.21 to $54.28, inclusive. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,097 | $53.60 | $58,798.10 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,548 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $53.30 to $54.12, inclusive. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,975 | $52.61 | $103,903.96 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,645 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $52.35 to $53.19, inclusive. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,314 | $51.55 | $170,844.65 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,620 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $51.21 to $51.96, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 22:15 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-051701 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-048107 · doc4.xml · derivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,525 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 4,359 | $47.53 | $207,170.19 |
DisclosureSEC source: 0001209191-20-048107 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,984 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $47.05 to $47.66, inclusive. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,591 | $46.42 | $120,274.22 |
DisclosureSEC source: 0001209191-20-048107 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,343 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $46.00 to $46.93, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:56 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-048107 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-043313 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,475 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 376 | $51.19 | $19,247.44 |
DisclosureSEC source: 0001209191-20-043313 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,984 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $51.18 to $51.21, inclusive. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 5,100 | $50.57 | $257,922.30 |
DisclosureSEC source: 0001209191-20-043313 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,360 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $50.16 to $50.90, inclusive. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,474 | $49.77 | $73,356.56 |
DisclosureSEC source: 0001209191-20-043313 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,460 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $49.01 to $49.95, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 20:47 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-043313 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:05 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,700 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001640147-20-000007 · primary_doc.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,425 Underlying: Common Stock · 2,700 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 23:05 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 2,700 | $10.29 | $27,783.00 |
DisclosureSEC source: 0001640147-20-000007 · primary_doc.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 3, 2020 01:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantRestricted Stock Units · Derivative | 14,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040815 · doc4.xml · derivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,476 Underlying: Common Stock · 14,476 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F3 · derivative.exercise_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. F3 · derivative.expiration_date: One-fourth (1/4th) of the restricted stock units vest on each of the first four anniversaries of June 15, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| June 30, 2020 Filed Jul 3, 2020 01:06 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | GrantStock Option (Right to Buy) · Derivative | 46,163 | $0.00 Strike: $54.12 | $0.00 |
DisclosureSEC source: 0001209191-20-040815 · doc4.xml · derivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,163 Underlying: Common Stock · 46,163 shares Expires 2030-06-29 F1 · derivative.exercise_date: One-forty-eighth (1/48th) of the shares subject to the option vests in equal monthly installments over four years measured from June 30, 2020, subject to Reporting Person's continued service on the applicable vesting date. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · derivative · entry 7 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,125 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 106 | $64.08 | $6,792.59 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,284 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $64.02 to $64.36, inclusive. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 723 | $62.92 | $45,491.88 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,390 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $62.65 to $63.20, inclusive. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,645 | $61.49 | $101,147.76 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,113 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $60.99 to $61.78, inclusive. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,684 | $60.33 | $101,600.77 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,758 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $59.98 to $60.93, inclusive. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,792 | $59.35 | $165,713.58 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,442 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $58.89 to $59.89, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:09 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-038752 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-031755 · doc4.xml · derivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,075 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,090 | $61.71 | $128,975.99 |
DisclosureSEC source: 0001209191-20-031755 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,284 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $61.18 to $62.10, inclusive. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 3,631 | $60.61 | $220,064.02 |
DisclosureSEC source: 0001209191-20-031755 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,374 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $60.06 to $60.99, inclusive. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,229 | $59.36 | $72,948.52 |
DisclosureSEC source: 0001209191-20-031755 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,005 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $58.72 to $59.705, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-031755 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · derivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,025 Underlying: Common Stock · 6,950 shares Expires 2028-08-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,924 | $55.20 | $106,200.95 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,284 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $55.08 to $56.04, inclusive. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 2,836 | $54.50 | $154,567.67 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,208 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $54.03 to $55.03, inclusive. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 551 | $53.34 | $29,390.34 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,044 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $53.00 to $53.82, inclusive. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 1,639 | $52.44 | $85,955.72 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,595 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $51.98 to $52.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Read SEC document |
| April 20, 2020 Filed Apr 22, 2020 21:01 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 6,950 | $10.29 | $71,515.50 |
DisclosureSEC source: 0001209191-20-025356 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · derivative · entry 6 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. F7 · derivative.exercise_date: 50% of the RSU vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSU vested 18 months after the Grant Date and 25% of the RSU vest 24 months after the Grant Date. F7 · derivative.expiration_date: 50% of the RSU vested 12 months after October 9, 2018 (the "Grant Date"), 25% of the RSU vested 18 months after the Grant Date and 25% of the RSU vest 24 months after the Grant Date. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 917 | $49.55 | $45,435.33 |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · nonDerivative · entry 5 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,284 F3 · shares: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F6 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $49.29 to $49.83, inclusive. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 345 | $48.70 | $16,803.09 |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · nonDerivative · entry 4 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,201 F3 · shares: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F5 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $48.185 to $49.00, inclusive. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 938 | $47.54 | $44,591.96 |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · nonDerivative · entry 3 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,546 F3 · shares: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. These sales were made to cover tax withholding obligations in connection with vesting and settlement of 25% of the Reporting Person's RSU granted on October 9, 2018. F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $47.095 to $48.045, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Tax withholdingCommon Stock | 4,058 | $50.67 | $205,618.86 |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · nonDerivative · entry 2 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,484 F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of 25% of the Reporting Person's restricted stock units granted on October 9, 2018. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:37 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-024246 · doc4.xml · nonDerivative · entry 1 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's common stock. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | Disposition to issuerStock Option (Right to Buy) · Derivative | 6,950 | $0.00 Strike: $10.29 | $0.00 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · derivative · entry 9 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,975 Underlying: Common Stock · 6,950 shares Expires 2029-12-29 F9 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter. Read SEC document |
| March 20, 2020 Filed Mar 24, 2020 20:45 UTC | Kodiak Sciences Inc. KOD · Entity 4388 | SaleCommon Stock | 128 | $48.59 | $6,219.14 |
DisclosureSEC source: 0001209191-20-020946 · doc4.xml · nonDerivative · entry 8 EHRLICH JASON · CIK 0001754049 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,542 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan. F8 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $48.385 to $48.755, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.